Aurora Cannabis: Underappreciated Turnaround (NASDAQ:ACB)
May 25, 2025
Aurora Cannabis’ strong adjusted EBITDA and low debt position set the stage for potential upside if growth continues. Read why ACB stock is a Buy.
Search
RECENT PRESS RELEASES
Related Post